JP2008298481A - Inspection sheet - Google Patents

Inspection sheet Download PDF

Info

Publication number
JP2008298481A
JP2008298481A JP2007142489A JP2007142489A JP2008298481A JP 2008298481 A JP2008298481 A JP 2008298481A JP 2007142489 A JP2007142489 A JP 2007142489A JP 2007142489 A JP2007142489 A JP 2007142489A JP 2008298481 A JP2008298481 A JP 2008298481A
Authority
JP
Japan
Prior art keywords
reagent holding
holding unit
skin
reagent
color
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007142489A
Other languages
Japanese (ja)
Other versions
JP4868409B2 (en
Inventor
Hiroshi Yamaguchi
博司 山口
Hideyasu Ishibashi
磴  秀康
Yoshiki Sakaino
佳樹 境野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Corp
Original Assignee
Fujifilm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corp filed Critical Fujifilm Corp
Priority to JP2007142489A priority Critical patent/JP4868409B2/en
Publication of JP2008298481A publication Critical patent/JP2008298481A/en
Application granted granted Critical
Publication of JP4868409B2 publication Critical patent/JP4868409B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide an inspection sheet for widely and accurately inspecting a state of the skin. <P>SOLUTION: The inspection sheet is equipped with a plurality of reagent holding parts containing the same reagent which changes in color by the contact with the secretion produced from the skin and respectively having difference in the change state of a color with respect to the same amount of the secretion. A plurality of the reagent holding parts may be different in the change quantity of the color per a unit time with respect to the same amount of the secretion. Further, a plurality of the reagent holding parts may be respectively different in the change start timing of the color with respect to the same amount of the secretion. <P>COPYRIGHT: (C)2009,JPO&INPIT

Description

本発明は、検査シートに関する。特に、本発明は、被検者の皮膚の状態を検査する検査シートに関する。   The present invention relates to an inspection sheet. In particular, the present invention relates to an inspection sheet for inspecting the skin condition of a subject.

特許文献1には、複数の試薬にそれぞれ水溶性ポリマー層を設け、検体が接触する時刻をそれぞれ異ならせる多項目尿試験紙が記載されている。さらに、特許文献2には、酵素含有試薬を有し、水和した時にグルコースと反応してインジケータの色を変える化学タイマが記載されている。
特開平9−96635号公報 特開平10−142225号公報
Patent Document 1 describes a multi-item urine test paper in which a plurality of reagents are each provided with a water-soluble polymer layer, and the time of contact with a specimen is different. Further, Patent Document 2 describes a chemical timer that has an enzyme-containing reagent and reacts with glucose to change the color of the indicator when hydrated.
JP-A-9-96635 Japanese Patent Laid-Open No. 10-142225

特許文献1および特許文献2では、全ての被検者に対して、同量の尿を用いて試験を実施して、最適のタイミングにおいて正しい色調を観察している。しかしながら、被検者の皮膚から分泌した分泌物で検査する場合、被検者ごと単位時間当たりの分泌量が異なるので、被検者ごとに水溶性ポリマー層の設定、または被検者ごとに検査時間を設定する必要がある。このため、全ての被検者が同じ検査シートを利用した場合、最適のタイミングにおいて、正しい色調を観察することは難しく、また様々な質感を有する全ての被検者の肌を、同じ検査シートで詳細に観察するのは難しい。   In Patent Document 1 and Patent Document 2, all subjects are tested using the same amount of urine, and the correct color tone is observed at the optimal timing. However, when testing with secretions secreted from the skin of a subject, the amount of secretion per unit time varies from subject to subject, so setting a water-soluble polymer layer for each subject, or testing for each subject It is necessary to set time. For this reason, when all subjects use the same inspection sheet, it is difficult to observe the correct color tone at the optimal timing, and the skin of all subjects having various textures can be observed on the same inspection sheet. It is difficult to observe in detail.

そこで本発明は、上記の課題を解決することができる検査シートを提供することを目的とする。この目的は特許請求の範囲における独立項に記載の特徴の組み合わせにより達成される。また従属項は本発明の更なる有利な具体例を規定する。   Then, an object of this invention is to provide the inspection sheet which can solve said subject. This object is achieved by a combination of features described in the independent claims. The dependent claims define further advantageous specific examples of the present invention.

上記課題を解決するために、本発明の第1の形態においては、検査シートは、皮膚から発生する分泌物と接触することによって色が変化する同一の試薬それぞれを含み、同一量の前記分泌物に対して、色の変化の状態がそれぞれ異なる複数の試薬保持部を備える。   In order to solve the above-described problem, in the first embodiment of the present invention, the test sheet includes the same reagent whose color changes by contact with the secretion generated from the skin, and the same amount of the secretion. On the other hand, a plurality of reagent holding parts having different color changes are provided.

複数の試薬保持部は、同一量の分泌物に対して、単位時間当たりの色の変化量がそれぞれ異なってもよい。また、複数の試薬保持部は、同一量の前記分泌物に対して、色の変化が開始するタイミングがそれぞれ異なってもよい。   The plurality of reagent holding units may have different color changes per unit time for the same amount of secretion. Moreover, the timing at which the color change starts for the plurality of reagent holding units may be different for the same amount of the secretion.

なお、上記の発明の概要は、本発明の必要な特徴の全てを列挙したものではなく、これらの特徴群のサブコンビネーションもまた、発明となりうる。   The above summary of the invention does not enumerate all the necessary features of the present invention, and sub-combinations of these feature groups can also be the invention.

以上の説明から明らかなように、本発明によれば、複数の試薬保持部がそれぞれ異なる反応態様を示すことで、より正確に検査結果を示すことができる。   As is clear from the above description, according to the present invention, the test results can be more accurately shown by the reaction states of the plurality of reagent holders being different from each other.

以下、発明の実施の形態を通じて本発明を説明するが、以下の実施形態は特許請求の範囲にかかる発明を限定するものではなく、また実施形態の中で説明されている特徴の組み合わせの全てが発明の解決手段に必須であるとは限らない。   Hereinafter, the present invention will be described through embodiments of the invention. However, the following embodiments do not limit the invention according to the scope of claims, and all combinations of features described in the embodiments are included. It is not necessarily essential for the solution of the invention.

図1は、検査シート1の正面図を示す。検査シート1は、色見本5、表シート6、透明シート11、透明シート11にそれぞれ被覆された第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14を備える。なお、本実施例では、検査シート1が試薬保持部を3つ備える場合を示すが、複数備えられていれば数は限定しない。   FIG. 1 shows a front view of the inspection sheet 1. The inspection sheet 1 includes a color sample 5, a front sheet 6, a transparent sheet 11, a first reagent holding unit 12, a second reagent holding unit 13, and a third reagent holding unit 14 covered with the transparent sheet 11, respectively. In this embodiment, the case where the test sheet 1 includes three reagent holding units is shown, but the number is not limited as long as a plurality of the test sheet 1 are provided.

第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14は、検査シート1の皮膚と接触する面に設けられる。透明シート11は、第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14のそれぞれを視認する面を被覆すると共に皮膚と接する面を有する。表シート6は、所定の色で透明シート11の皮膚に接する面と対面に設けられている。また、表シート6は、第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14のそれぞれを、透明シート11を介して視認できる位置に透孔を有する。色見本5は、表シート6の透明シート11と接する面と対面上の任意の位置に設けられる。なお、検査シート1は、検査が実施される前において、皮膚との貼付面に剥離シートを備える。さらに、検査シート1は、剥離シートと透明シート11との間に粘着層を備える。   The first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14 are provided on the surface of the test sheet 1 that contacts the skin. The transparent sheet 11 has a surface that covers each of the first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14 and that is in contact with the skin. The front sheet 6 is provided on a surface facing the skin of the transparent sheet 11 with a predetermined color. Further, the front sheet 6 has a through hole at a position where each of the first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14 can be visually recognized through the transparent sheet 11. The color sample 5 is provided at an arbitrary position on the face of the front sheet 6 that is in contact with the transparent sheet 11. Note that the inspection sheet 1 includes a release sheet on the surface to be adhered to the skin before the inspection is performed. Furthermore, the inspection sheet 1 includes an adhesive layer between the release sheet and the transparent sheet 11.

第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14は、それぞれ被検者の皮膚から発生する分泌物と接触することで色が変化する同一の試薬を含む。第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14は、同一量の分泌物に対して、色の変化の状態がそれぞれ異なる。それぞれの試薬は、検査シート1が貼付された領域の一部に含まれる皮膚の表面の水分または皮脂等の存在により変色する。具体的には、被検者の水分を計測する場合、第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14は無水塩化コバルト塩を試薬として含み、無水塩化コバルト塩の青は、被検者から蒸散した水分に反応することで、塩化コバルト六水和物の赤に変化する。なお、試薬はpH指示薬等であってもよい。   The 1st reagent holding part 12, the 2nd reagent holding part 13, and the 3rd reagent holding part 14 contain the same reagent from which a color changes by contacting with the secretions which generate | occur | produce from a subject's skin, respectively. The first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14 have different color change states with respect to the same amount of secretion. Each reagent changes color due to the presence of moisture or sebum on the surface of the skin contained in a part of the region where the test sheet 1 is affixed. Specifically, when measuring the moisture of the subject, the first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14 contain anhydrous cobalt chloride salt as a reagent, and anhydrous cobalt chloride salt The blue color changes to red for cobalt chloride hexahydrate by reacting to the water evaporated from the subject. The reagent may be a pH indicator or the like.

第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14は、同一量の分泌物に対して、単位時間当たりの色の変化量がそれぞれ異なる。即ち、第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14は、検査開始から、それぞれが異なった反応速度または異なった反応開始タイミングで分泌物と反応して呈色反応を示す。ここで、被検者の皮膚から発生する分泌物とは、液体、水分、油分、汗、または皮脂等であってもよい。変色した第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14は、一定時間経過後に、それぞれが呈する色の組み合わせが示された色見本5と比較されて、被検者の皮膚の状態が判断される。なお、第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14と皮膚とが接触する面に、第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14が保持する試薬と皮膚とが直接に接触することを避けるべく、水分または皮脂を透過するが試薬を透過しない不織布等の層を備えてもよい。   The first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14 have different amounts of color change per unit time for the same amount of secretion. That is, the first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14 are colored by reacting with secretions at different reaction rates or different reaction start timings from the start of the test. Shows the reaction. Here, the secretion generated from the skin of the subject may be liquid, moisture, oil, sweat, sebum, or the like. The first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14, which have changed color, are compared with the color sample 5 in which a combination of colors exhibited by each color is shown after a certain period of time. The condition of the person's skin is determined. The first reagent holding unit 12, the second reagent holding unit 13, and the third reagent are arranged on the surface where the first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14 are in contact with the skin. In order to avoid direct contact between the reagent held by the holding unit 14 and the skin, a layer such as a non-woven fabric that transmits moisture or sebum but does not transmit the reagent may be provided.

透明シート11は、柔軟性を有し、透明性に優れ、また強靭性にも優れた樹脂フィルムが好ましい。具体的には、高分子樹脂フィルムであってよく、例えば、ポリ塩化ビニル、ポリ塩化ビニリデン、ポリビニルアルコール、ポリエステル、ポリエチレン、ポリプロピレン、ポリウレタン、ポリオレフィン、およびポリアミド系合成繊維等であってよい。高分子樹脂フィルムの重合度および平均分子量等は、検査シート1の使用状況、並びに検査シート1に要求される柔軟性、および耐久性等に応じて適宜決定してよい。   The transparent sheet 11 is preferably a resin film having flexibility, excellent transparency, and excellent toughness. Specifically, it may be a polymer resin film, such as polyvinyl chloride, polyvinylidene chloride, polyvinyl alcohol, polyester, polyethylene, polypropylene, polyurethane, polyolefin, and polyamide-based synthetic fiber. The degree of polymerization, the average molecular weight, and the like of the polymer resin film may be appropriately determined according to the usage state of the inspection sheet 1 and the flexibility and durability required for the inspection sheet 1.

色見本5は、検査開始から一定時間経過後における、第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14が呈する色の組み合わせを示す。また、色見本5は、第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14が呈する色の組み合わせに対応する皮膚の状態の指標を示す。   The color sample 5 indicates a combination of colors exhibited by the first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14 after a predetermined time has elapsed from the start of the test. Further, the color sample 5 indicates an index of the skin state corresponding to the combination of colors exhibited by the first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14.

また、検査シート1、検査シート1を撮像する撮像装置30、および解析装置40を備える検査システムであってもよい。検査システムは、皮膚に貼り付けられた検査シート1を撮像装置30で撮像して、皮膚の状態を検査する。   Further, the inspection system may include an inspection sheet 1, an imaging device 30 that images the inspection sheet 1, and an analysis device 40. The inspection system images the inspection sheet 1 attached to the skin with the imaging device 30 to inspect the skin state.

まず、検査シート1は、人体の皮膚に貼付される。第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14が保持する試薬は、検査シート1が貼付された領域の一部に含まれる皮膚の表面の水分または皮脂等の存在により変色する。そして、撮像装置30は、透明シート11のそれぞれを透過した光を撮像して、撮像した画像を示す撮像画像データを、ネットワーク50を介して解析装置40に送信する。解析装置40は、撮像画像データが示す撮像画像から、皮膚の状態を解析する。   First, the test sheet 1 is affixed to the human skin. The reagents held by the first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14 are moisture or sebum on the surface of the skin included in a part of the region to which the test sheet 1 is attached. Discolors due to existence. The imaging device 30 captures the light transmitted through each of the transparent sheets 11 and transmits captured image data indicating the captured image to the analysis device 40 via the network 50. The analysis device 40 analyzes the skin state from the captured image indicated by the captured image data.

撮像装置30は、検査シート1を撮像する。撮像装置30が撮像した撮像画像を示す撮像画像データは、LANおよびインターネット等のネットワーク50を介して、撮像画像を解析して皮膚の状態を判断する解析装置40に送信される。また、撮像装置30は、撮像装置30を電気通信的に接続可能なクレードルに保持されてよい。そして、クレードルはネットワーク50を介して解析装置40と通信可能に接続される。係る場合に、撮像装置30は、クレードルを介して解析装置40に撮像画像データを送信してもよい。   The imaging device 30 images the inspection sheet 1. The captured image data indicating the captured image captured by the imaging device 30 is transmitted to the analysis device 40 that analyzes the captured image and determines the state of the skin via a network 50 such as a LAN and the Internet. Further, the imaging device 30 may be held in a cradle that can connect the imaging device 30 in an electric communication manner. The cradle is communicably connected to the analysis device 40 via the network 50. In such a case, the imaging device 30 may transmit the captured image data to the analysis device 40 via a cradle.

解析装置40は、撮像装置30が撮像した検査シート1の撮像画像から、皮膚の状態を解析する。解析装置40は、PCまたはサーバであってよい。具体的には、解析装置40は、第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14が呈した色をそれぞれ取得し、それら色の組み合わせと、解析装置40が有する色の組み合わせに対応する皮膚の状態を示す色見本データとから皮膚の状態を解析する。   The analysis device 40 analyzes the state of the skin from the captured image of the inspection sheet 1 captured by the imaging device 30. The analysis device 40 may be a PC or a server. Specifically, the analysis device 40 acquires the colors exhibited by the first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14, respectively, and the combination of these colors and the analysis device 40 The skin state is analyzed from color sample data indicating the skin state corresponding to the combination of colors.

図2は、色見本5の正面図を示す。色見本5は、検査後に第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14のそれぞれが示す色の違いを列方向に示す。また、色見本5は、検査後に第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14のそれぞれが示す色の組み合わせを行方向に示す。さらに、色見本5は、第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14のそれぞれが示す色の組み合わせ、即ち行方向にあわせて、被検者の皮膚の状態の指標を示す。第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14のそれぞれが呈する色と、色見本5が示す第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14の色の組み合わせとから、皮膚の状態を判断する。   FIG. 2 shows a front view of the color sample 5. The color swatch 5 indicates the color difference indicated by each of the first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14 in the column direction after the inspection. Moreover, the color sample 5 shows the color combination which each of the 1st reagent holding | maintenance part 12, the 2nd reagent holding | maintenance part 13, and the 3rd reagent holding | maintenance part 14 shows after a test | inspection in a row direction. Furthermore, the color sample 5 is a combination of the colors indicated by the first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14, that is, the state of the subject's skin according to the row direction. The indicator of The color exhibited by each of the first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14, and the first reagent holding unit 12, the second reagent holding unit 13, and the third color sample 5 indicate. The state of the skin is determined from the color combination of the reagent holding unit 14.

図3は、検査シート1の側方断面図の第一の実施形態を示す。検査シート1は、色見本5、表シート6、第一透過部7、第二透過部8、第三透過部9、粘着層10、透明シート11、第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14を備える。   FIG. 3 shows a first embodiment of a side sectional view of the inspection sheet 1. The inspection sheet 1 includes a color sample 5, a front sheet 6, a first transmission part 7, a second transmission part 8, a third transmission part 9, an adhesive layer 10, a transparent sheet 11, a first reagent holding part 12, and a second reagent holding. Unit 13 and third reagent holding unit 14.

第一透過部7、第二透過部8、第三透過部9は、それぞれ検査シート1の皮膚に接触する位置に設けられる。そして、第一透過部7、第二透過部8、第三透過部9は、第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14の皮膚に対向する面に隣接してそれぞれ設けられ、分泌物をそれぞれ透過する。第一試薬保持部12は、第一透過部7の上面、即ち、第一透過部7の皮膚に接触する面と反対の面に接触して配置される。第二試薬保持部13は、第二透過部8の上面、即ち、第二透過部8の皮膚に接触する面と反対の面に接触して配置される。第三試薬保持部14は、第三透過部9の上面、即ち、第三透過部9の皮膚と接触する面と反対の面に接触して配置される。なお、第一透過部7、第二透過部8、第三透過部9は、アセチルセルロース、ポリスルホン、ニトロセルロース、ポリ塩化ビニリデン等の多孔質材料で形成される。   The first transmission part 7, the second transmission part 8, and the third transmission part 9 are provided at positions that contact the skin of the test sheet 1, respectively. And the 1st permeation | transmission part 7, the 2nd permeation | transmission part 8, and the 3rd permeation | transmission part 9 are adjacent to the surface facing the skin of the 1st reagent holding part 12, the 2nd reagent holding part 13, and the 3rd reagent holding part 14. Are provided, and pass through the secretions. The first reagent holding unit 12 is disposed in contact with the upper surface of the first transmission unit 7, that is, the surface opposite to the surface of the first transmission unit 7 that contacts the skin. The second reagent holding unit 13 is arranged in contact with the upper surface of the second transmission unit 8, that is, the surface opposite to the surface of the second transmission unit 8 that contacts the skin. The third reagent holding unit 14 is disposed in contact with the upper surface of the third transmission unit 9, that is, the surface opposite to the surface of the third transmission unit 9 that contacts the skin. In addition, the 1st permeation | transmission part 7, the 2nd permeation | transmission part 8, and the 3rd permeation | transmission part 9 are formed with porous materials, such as acetylcellulose, a polysulfone, a nitrocellulose, and a polyvinylidene chloride.

透明シート11は、第一透過部7、第二透過部8、および第三透過部9の上面に接触して配置される。透明シート11は、第一透過部7、第二透過部8、および第三透過部9、並びに第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14を被覆する。また、粘着層10は、透明シート11の下面、即ち、透明シート11の皮膚と対向する面に設けられる。なお、粘着層10は、例えば、アクリル系粘着剤であってよい。   The transparent sheet 11 is arranged in contact with the upper surfaces of the first transmission part 7, the second transmission part 8, and the third transmission part 9. The transparent sheet 11 covers the first transmission part 7, the second transmission part 8, and the third transmission part 9, as well as the first reagent holding part 12, the second reagent holding part 13, and the third reagent holding part 14. The adhesive layer 10 is provided on the lower surface of the transparent sheet 11, that is, the surface of the transparent sheet 11 that faces the skin. In addition, the adhesion layer 10 may be an acrylic adhesive, for example.

表シート6は、透明シート11の上面、即ち、第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14に接触する面と反対の面に接触して配置される。表シート6は、第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14のそれぞれを、透明シート11を介して視認できる位置に透孔を有する。色見本5は、表シート6の透明シート11に接触する面と反対の面上に設けられる。   The front sheet 6 is disposed in contact with the upper surface of the transparent sheet 11, that is, the surface opposite to the surface in contact with the first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14. The front sheet 6 has through holes at positions where the first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14 can be visually recognized through the transparent sheet 11. The color sample 5 is provided on the surface of the front sheet 6 opposite to the surface that contacts the transparent sheet 11.

第一透過部7は、皮膚から第一試薬保持部12に貫通する複数の貫通孔を有する。第二透過部8は、皮膚から第二試薬保持部13に貫通する複数の貫通孔を有する。第三透過部9は、皮膚から第三試薬保持部14に貫通する複数の貫通孔を有する。第一透過部7、第二透過部8、および第三透過部9がそれぞれ有する複数の貫通孔は、それぞれの透過部ごとに、大きさがそれぞれ異なる。例えば、第一透過部7、第二透過部8、および第三透過部9は、それぞれ大、中、小の大きさの貫通孔を有するものとする。即ち、一定の皮膚から分泌される分泌物の蒸散量に対して、第一透過部7は、多くの分泌物を第一試薬保持部12へと透過する。また、第二透過部8は、中程度の分泌物を第二試薬保持部13へと透過する。さらに、第三透過部は、少ない分泌物を第三試薬保持部14へと透過する。   The first permeation unit 7 has a plurality of through holes that penetrate from the skin to the first reagent holding unit 12. The 2nd permeation | transmission part 8 has a some through-hole penetrated to the 2nd reagent holding | maintenance part 13 from skin. The third permeable part 9 has a plurality of through holes that penetrate from the skin to the third reagent holding part 14. The plurality of through holes included in each of the first transmission unit 7, the second transmission unit 8, and the third transmission unit 9 have different sizes for each transmission unit. For example, the 1st permeation | transmission part 7, the 2nd permeation | transmission part 8, and the 3rd permeation | transmission part 9 shall have a through-hole of a large, medium, and small magnitude | size, respectively. That is, the first permeation unit 7 permeates a large amount of secretions to the first reagent holding unit 12 with respect to the transpiration amount of the secretion secreted from a certain skin. Further, the second permeation unit 8 permeates the medium secretion to the second reagent holding unit 13. Further, the third permeation part permeates a small amount of secretions to the third reagent holding part 14.

第一透過部7、第二透過部8、および第三透過部9のそれぞれは、透過部ごとに異なった大きさの貫通孔を含むことで、検査開始後、単位時間当たりに皮膚から第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14のそれぞれに到達させる分泌物の量がそれぞれ異なる。なお、第一透過部7、第二透過部8、および第三透過部9のそれぞれは、単位面積当たりの数が透過部ごとにそれぞれ異なる同一の大きさの貫通孔を有していても良い。検査開始から一定時間経過後において、第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14は、それぞれが接する透過部から浸透する分泌物の量がそれぞれ異なることで、それぞれ異なった色の変化量を示す。   Each of the first transmission part 7, the second transmission part 8, and the third transmission part 9 includes through-holes having different sizes for each transmission part. The amounts of secretions that reach the reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14 are different. In addition, each of the 1st permeation | transmission part 7, the 2nd permeation | transmission part 8, and the 3rd permeation | transmission part 9 may have the through-hole of the same magnitude | size from which the number per unit area differs for every permeation | transmission part. . After a lapse of a certain time from the start of the test, the first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14 are different from each other in the amount of secretion that permeates from the permeation unit in contact with each other. Each shows a different amount of color change.

図4は、本発明の第一実施形態に係る試薬保持部の色の変化を示す。図4において、縦軸はそれぞれの試薬保持部の色の変化量を示し、横軸は皮膚から分泌した分泌物の蒸散量を示す。皮膚からの分泌物の蒸散量に対する、第一試薬保持部12の色の変化量をaに示す。皮膚からの分泌物の蒸散量に対する、第二試薬保持部13の色の変化量をbに示す。皮膚からの分泌物の蒸散量に対する、第三試薬保持部14の色の変化量をcに示す。なお、色の変化量とは、色相の変化量の他に、色が濃くなっていく量、および色が淡くなっていく量も含む。また、蒸散量に対するそれぞれの試薬保持部の色の変化する速さは、a、b、およびcの傾きで表される。   FIG. 4 shows changes in the color of the reagent holding unit according to the first embodiment of the present invention. In FIG. 4, the vertical axis represents the amount of change in color of each reagent holding portion, and the horizontal axis represents the transpiration amount of the secretion secreted from the skin. A change amount of the color of the first reagent holding unit 12 with respect to the transpiration amount of the secretion from the skin is shown in a. The amount of change in the color of the second reagent holding unit 13 with respect to the amount of transpiration from the skin is shown in b. The amount of change in the color of the third reagent holding unit 14 with respect to the amount of transpiration of the secretion from the skin is shown in c. The color change amount includes, in addition to the hue change amount, an amount that the color becomes darker and an amount that the color becomes lighter. Further, the speed at which the color of each reagent holder changes with respect to the amount of transpiration is represented by the slopes of a, b, and c.

検査開始から一定時間経過後における皮膚からの分泌物の蒸散量がkであった場合、第一試薬保持部12は、多くの試薬が反応して既に色が十分変化している状態を示す。第二試薬保持部13は、色変化が進行途上で、試薬の半分以上が変化した状態を示す。第三試薬保持部14は、色変化が進行途上で、試薬の約半分が変化した状態を示す。このように、第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14のそれぞれが含む試薬は、異なった反応速度で色変化する。   When the transpiration amount of the secretion from the skin after a lapse of a certain time from the start of the test is k, the first reagent holding unit 12 shows a state where the color has already sufficiently changed due to the reaction of many reagents. The second reagent holding unit 13 shows a state in which more than half of the reagent has changed while the color change is in progress. The third reagent holding unit 14 shows a state in which about half of the reagent has changed while the color change is in progress. As described above, the reagents included in each of the first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14 change in color at different reaction rates.

第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14のそれぞれが含む試薬の反応速度を異ならせることで、試薬保持部が一つである場合に対して、正確な皮膚の状態を検査できる。さらには、様々な皮膚の状態をより幅広く検査することができる。例えば、皮膚が乾燥しており、分泌物の蒸散量が極端に少ない皮膚を検査した場合であっても、第一試薬保持部12が含む試薬の色が大きく変化する。したがって、乾燥した皮膚の蒸散量を正確に検査できる。また、皮膚がよく潤っており、分泌物の蒸散量が極端に多い皮膚を検査した場合であっても、第三試薬保持部14が含む試薬の色は、飽和することなく、変化し続ける。したがって、よく潤った皮膚の蒸散量も正確に検査できる。ゆえに、一つの検査シート1で、様々な皮膚の状態を検査することができる。   By differentiating the reaction rates of the reagents included in each of the first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14, it is possible to accurately match the case where there is one reagent holding unit. Can examine skin condition. Furthermore, various skin conditions can be examined more widely. For example, even when the skin is dry and the skin where the amount of transpiration of the secretion is extremely small is examined, the color of the reagent included in the first reagent holding unit 12 changes greatly. Therefore, the amount of transpiration of dry skin can be accurately inspected. Further, even when the skin is well moistened and the skin where the amount of transpiration of the secretion is extremely large is examined, the color of the reagent included in the third reagent holding unit 14 continues to change without being saturated. Therefore, the amount of transpiration of well moistened skin can be accurately inspected. Therefore, various skin conditions can be inspected with one inspection sheet 1.

図5は、検査シート1の側方断面図の第二の実施形態を示す。検査シート1は、色見本5、表シート6、粘着層10、透明シート11、第一試薬保持部12、第二試薬保持部13、第三試薬保持部14、第一透過部24、第二透過部25、および第三透過部26を備える。   FIG. 5 shows a second embodiment of a side sectional view of the inspection sheet 1. The test sheet 1 includes a color sample 5, a front sheet 6, an adhesive layer 10, a transparent sheet 11, a first reagent holding unit 12, a second reagent holding unit 13, a third reagent holding unit 14, a first permeation unit 24, and a second. A transmission part 25 and a third transmission part 26 are provided.

なお、本実施形態に係る検査シート1は、第一透過部24、第二透過部25、および第三透過部26が、それぞれ透過層および吸収材料を有する点を除き、図1から図4の上記説明における検査シート1と略同一の機能および構成を有する。従って、以下の説明においては、第一透過部24、第二透過部25、および第三透過部26を除く他の構成要素についての詳細な説明は省略する。   In addition, the inspection sheet 1 according to the present embodiment includes the first transmission part 24, the second transmission part 25, and the third transmission part 26 shown in FIGS. 1 to 4 except that each has a transmission layer and an absorbent material. It has substantially the same function and configuration as the inspection sheet 1 in the above description. Therefore, in the following description, detailed description of the other components excluding the first transmission part 24, the second transmission part 25, and the third transmission part 26 is omitted.

第一透過部24は、第一試薬保持部12の皮膚と対向する面に隣接して設けられる。第一透過部24は、第一透過層15と、第一吸収材料18とを有する。第一透過層15は、第一透過部24の皮膚と接触する面に設けられる。また、第一吸収材料18は、第一透過部24の第一試薬保持部12と接する面に設けられる。   The first permeation unit 24 is provided adjacent to the surface of the first reagent holding unit 12 that faces the skin. The first transmission part 24 includes the first transmission layer 15 and the first absorbent material 18. The first transmission layer 15 is provided on the surface of the first transmission part 24 that contacts the skin. The first absorbent material 18 is provided on the surface of the first permeation unit 24 that contacts the first reagent holding unit 12.

第二透過部25は、第二試薬保持部13の皮膚と対向する面に隣接して設けられる。第二透過部25は、第二透過層16と、第二吸収材料19とを有する。第二透過層16は、第二透過部25の皮膚と接触する面に設けられる。また、第二吸収材料19は、第二透過部25の第二試薬保持部13と接する面に設けられる。   The 2nd permeation | transmission part 25 is provided adjacent to the surface facing the skin of the 2nd reagent holding | maintenance part 13. FIG. The second transmission part 25 includes the second transmission layer 16 and the second absorbent material 19. The second transmission layer 16 is provided on the surface of the second transmission part 25 that comes into contact with the skin. The second absorbent material 19 is provided on the surface of the second permeation unit 25 that contacts the second reagent holding unit 13.

第三透過部26は、第三試薬保持部14の皮膚と対向する面に隣接して設けられる。第三透過部26は、第三透過層17と、第三吸収材料20とを有する。第三透過層17は、第三透過部26の皮膚と接触する面に設けられる。また、第三吸収材料20は、第三透過部26の第三試薬保持部14と接する面に設けられる。   The third permeation part 26 is provided adjacent to the surface of the third reagent holding part 14 facing the skin. The third transmission part 26 includes the third transmission layer 17 and the third absorbent material 20. The third transmission layer 17 is provided on the surface of the third transmission part 26 that contacts the skin. The third absorbent material 20 is provided on the surface of the third permeation portion 26 that contacts the third reagent holding portion 14.

第一透過層15、第二透過層16、および第三透過層17は、それぞれが皮膚から同量の分泌物を、第一吸収材料18、第二吸収材料19、および第三吸収材料20へと浸透させる。第一吸収材料18、第二吸収材料19、および第三吸収材料20は、それぞれ第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14のそれぞれよりも先に、皮膚からの分泌物を吸収する。具体的には、塩化コバルトを試薬として皮膚の水分を検査する場合、第一吸収材料18、第二吸収材料19、および第三吸収材料20は、シリカゲル、ゼオライト等の水分吸収部材を用いる。第一吸収材料18、第二吸収材料19、および第三吸収材料20は、皮膚からの分泌物を十分吸収した後、第一試薬保持部12、第二試薬保持部13および第三試薬保持部14へ、皮膚からの分泌物を浸透させる。   The first permeable layer 15, the second permeable layer 16, and the third permeable layer 17 each transfer the same amount of secretion from the skin to the first absorbent material 18, the second absorbent material 19, and the third absorbent material 20. And infiltrate. The first absorbent material 18, the second absorbent material 19, and the third absorbent material 20 are placed on the skin before the first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14, respectively. Absorbs secretions from Specifically, when examining moisture in the skin using cobalt chloride as a reagent, the first absorbent material 18, the second absorbent material 19, and the third absorbent material 20 use a moisture absorbing member such as silica gel or zeolite. The first absorbent material 18, the second absorbent material 19, and the third absorbent material 20 absorb the secretion from the skin sufficiently, and then the first reagent holding part 12, the second reagent holding part 13, and the third reagent holding part. 14 infiltrate the secretions from the skin.

第一吸収材料18、第二吸収材料19、および第三吸収材料20は、分泌物の吸収量がそれぞれ異なるように設計されている。即ち、第一吸収材料18、第二吸収材料19、および、第三吸収材料20は、それぞれが異なった厚さ、または異なった部材を有して、それぞれ異なった時間で飽和状態となる。その結果、第一吸収材料18、第二吸収材料19、および第三吸収材料20は、それぞれ異なった時間で第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14へと分泌物を到達させる。そして、第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14は、同一量の前記分泌物に対して、それぞれ異なったタイミングで分泌物と反応して色変化する。なお、第一吸収材料18、第二吸収材料19、または第三吸収材料20のいずれか一つが、分泌物を吸収しない構造であってもよい。即ち、第一吸収材料18が分泌物を吸収しない構造であったとすると、第一吸収材料18は、第一透過層15を浸透した分泌物をそのまま透過して、第一試薬保持部12へと到達させる。この場合、第一試薬保持部12は、検査開始から分泌物による色変化を開始する。本実施形態では、第一吸収材料18が分泌物を吸収しない構造であり、第二吸収材料19が少ない、第三吸収材料が多い分泌物の吸収量を有する場合で説明する。   The 1st absorption material 18, the 2nd absorption material 19, and the 3rd absorption material 20 are designed so that the absorption amount of a secretion may differ, respectively. That is, the first absorbent material 18, the second absorbent material 19, and the third absorbent material 20 have different thicknesses or different members, and become saturated at different times. As a result, the first absorbent material 18, the second absorbent material 19, and the third absorbent material 20 are transferred to the first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14 at different times. And let the secretions reach. The first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14 react with the secretion at different timings and change color with respect to the same amount of the secretion. Note that any one of the first absorbent material 18, the second absorbent material 19, and the third absorbent material 20 may have a structure that does not absorb secretions. That is, assuming that the first absorbent material 18 has a structure that does not absorb secretions, the first absorption material 18 passes through the secretions that have permeated the first permeable layer 15 as it is to the first reagent holding unit 12. To reach. In this case, the first reagent holding unit 12 starts the color change due to the secretion from the start of the test. In the present embodiment, the first absorbent material 18 has a structure that does not absorb secretions, and the case where the second absorbent material 19 is small and the third absorbent material has a large amount of secretions will be described.

図6は、本発明の第二実施形態に係る試薬保持部の色の変化を示す。図6において、縦軸はそれぞれの試薬保持部の色の変化量を示し、横軸は皮膚から分泌した分泌物の蒸散量を示す。皮膚からの分泌物の蒸散量に対する、第一試薬保持部12の色の変化量をaに示す。皮膚からの分泌物の蒸散量に対する、第二試薬保持部13の色の変化量をbに示す。皮膚からの分泌物の蒸散量に対する、第三試薬保持部14の色の変化量をcに示す。なお、色の変化量とは、色相の変化量の他に、色が濃くなっていく量、および色が淡くなっていく量も含む。また、蒸散量に対するそれぞれの試薬保持部の色の変化する速さは、a、b、およびcの傾きで表される。   FIG. 6 shows the color change of the reagent holding part according to the second embodiment of the present invention. In FIG. 6, the vertical axis represents the amount of change in color of each reagent holding portion, and the horizontal axis represents the transpiration amount of the secretion secreted from the skin. A change amount of the color of the first reagent holding unit 12 with respect to the transpiration amount of the secretion from the skin is shown in a. The amount of change in the color of the second reagent holding unit 13 with respect to the amount of transpiration from the skin is shown in b. The amount of change in the color of the third reagent holding unit 14 with respect to the amount of transpiration of the secretion from the skin is shown in c. The color change amount includes, in addition to the hue change amount, an amount that the color becomes darker and an amount that the color becomes lighter. Further, the speed at which the color of each reagent holder changes with respect to the amount of transpiration is represented by the slopes of a, b, and c.

検査を開始すると、第一試薬保持部12は、分泌物の蒸散量がlになるまで色変化して、蒸散量lにおいて色変化が終了する。第二試薬保持部13は、皮膚からの分泌物の蒸散量がlに達した場合に、皮膚からの分泌物との反応を開始する。第二試薬保持部13は、皮膚からの分泌物が蒸散量lに達した場合に反応を開始して、蒸散量lにおいて色変化が終了する。第三試薬保持部14は、皮膚からの分泌物の蒸散量がlに達した場合に、皮膚からの分泌物との反応を開始する。第三試薬保持部14は、皮膚からの分泌物が蒸散量lに達した場合に反応を開始して、蒸散量lになるまで色変化して、蒸散量lにおいて色変化が終了する。 When starting the test, the first reagent holding portion 12, transpiration of secretions and color change until l 1, color change ends at transpiration rate l 1. Second reagent holding portion 13, transpiration of secretions from the skin when reached l 1, to initiate the reaction with the secretions from the skin. The second reagent holding unit 13 starts the reaction when the secretion from the skin reaches the transpiration amount l 1 , and the color change ends at the transpiration amount l 2 . The third reagent holder 14, transpiration of secretions from the skin when reached l 2, to initiate the reaction with the secretions from the skin. The third reagent holder 14, secretions from the skin starts to react when it reaches the transpiration rate l 2, and a color change to a transpiration l 3, color change ends at transpiration l 3 To do.

検査開始から一定時間経過後における皮膚からの分泌物の蒸散量がkであった場合、第一試薬保持部12および第二試薬保持部13は、それぞれ多くの試薬が反応して既に色が十分変化している状態を示す。第三試薬保持部14は、色変化が進行途上で、試薬の1/4程度が変化した状態を示す。このように、それぞれの試薬保持部は、蒸散量にあわせて順次反応していく。   When the amount of transpiration of the secretion from the skin after a lapse of a certain time from the start of the test is k, the first reagent holding unit 12 and the second reagent holding unit 13 are already sufficiently colored due to the reaction of many reagents. Indicates a changing state. The third reagent holding unit 14 shows a state in which about ¼ of the reagent has changed while the color change is in progress. Thus, each reagent holding part reacts sequentially according to the amount of transpiration.

第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14は、それぞれが順次反応するので、水分が極端に多い被検者、または水分が極端に少ない被検者に対して、どちらにも同じ時間で正確な検査を実施できる。また、第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14のそれぞれが別々に反応するので、検査シート1を厚くすることなく、長時間の検査をすることができる。即ち、分泌物の蒸散量がlに達するまで検査することができる。 Since each of the first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14 sequentially reacts, a subject with extremely high water content or a subject with extremely low water content In both cases, accurate inspection can be performed at the same time. Further, since each of the first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14 reacts separately, it is possible to inspect for a long time without increasing the thickness of the inspection sheet 1. . That is, it is possible to transpiration secretions are examined until a l 3.

図7は、本発明の第二実施形態に係る試薬保持部の色の変化における別の例を示す。図7において、縦軸はそれぞれの試薬保持部の色の変化量を示し、横軸は皮膚から分泌した分泌物の蒸散量を示す。皮膚からの分泌物の蒸散量に対する、第一試薬保持部12の色の変化量をaに示す。皮膚からの分泌物の蒸散量に対する、第二試薬保持部13の色の変化量をbに示す。皮膚からの分泌物の蒸散量に対する、第三試薬保持部14の色の変化量をcに示す。なお、色の変化量とは、色相の変化量の他に、色が濃くなっていく量、および色が淡くなっていく量も含む。また、蒸散量に対するそれぞれの試薬保持部の色の変化する速さは、a、b、およびcの傾きで表される。   FIG. 7 shows another example of the color change of the reagent holding unit according to the second embodiment of the present invention. In FIG. 7, the vertical axis indicates the amount of change in color of each reagent holding portion, and the horizontal axis indicates the transpiration amount of the secretion secreted from the skin. A change amount of the color of the first reagent holding unit 12 with respect to the transpiration amount of the secretion from the skin is shown in a. The amount of change in the color of the second reagent holding unit 13 with respect to the amount of transpiration from the skin is shown in b. The amount of change in the color of the third reagent holding unit 14 with respect to the amount of transpiration of the secretion from the skin is shown in c. The color change amount includes, in addition to the hue change amount, an amount that the color becomes darker and an amount that the color becomes lighter. Further, the speed at which the color of each reagent holder changes with respect to the amount of transpiration is represented by the slopes of a, b, and c.

検査開始から一定時間経過後における、分泌物の蒸散量がkであった場合、第一試薬保持部12は、それぞれ多くの試薬が反応して既に色が十分変化している状態を示す。第二試薬保持部13は、色変化が進行途上で、試薬の2/3程度が変化した状態を示す。また、第三試薬保持部14は、色変化が進行途上で、試薬の1/3程度が変化した状態を示す。このように、第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14のそれぞれが含む試薬は、異なったタイミングで変化を開始して、同じ速度で色変化する。   When the amount of transpiration of the secreted substance after the elapse of a certain time from the start of the test is k, the first reagent holding unit 12 shows a state where the color has already sufficiently changed due to the reaction of many reagents. The second reagent holding unit 13 shows a state in which about 2/3 of the reagent has changed while the color change is in progress. Further, the third reagent holding unit 14 shows a state in which about 1/3 of the reagent has changed while the color change is in progress. As described above, the reagent included in each of the first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14 starts changing at different timings and changes color at the same speed.

複数の試薬保持部を備え、それぞれの試薬保持部が含む試薬に、色変化の開始タイミングを異ならせることで、試薬保持部が一つである場合に対して、正確な皮膚の状態を検査できる。さらには、検査シート1が、複数の試薬保持部を備えることで、様々な皮膚の状態をより幅広く検査することができる。例えば、皮膚が乾燥し、分泌物の蒸散量が極端に少ない皮膚を検査した場合、第一試薬保持部12が含む試薬は、少ない蒸散量に対して変化を開始する。また、皮膚がよく潤っており、分泌物の蒸散量が極端に多い皮膚を検査した場合、第三試薬保持部14が含む試薬の色は、多い蒸散量に対して遅い開始タイミングで色変化を開始する。ゆえに、一つの検査シート1で、様々な皮膚の状態を有する被検者を検査することができる。   By providing a plurality of reagent holders and changing the color change start timing for the reagents contained in each reagent holder, it is possible to accurately inspect the skin condition when there is only one reagent holder. . Furthermore, since the test sheet 1 includes a plurality of reagent holders, various skin conditions can be examined more widely. For example, when the skin is dried and the skin where the amount of transpiration of the secretion is extremely small is examined, the reagent included in the first reagent holding unit 12 starts to change with respect to the amount of transpiration. In addition, when the skin is well moistened and the skin where the amount of transpiration of the secretion is extremely large is examined, the color of the reagent included in the third reagent holding unit 14 changes at a late start timing with respect to the large amount of transpiration. Start. Therefore, it is possible to inspect subjects having various skin conditions with one inspection sheet 1.

第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14は、それぞれが異なった反応タイミングで色反応するとともに、同じ速度で分泌物と色反応するので、試薬保持部がひとつである場合に対して、正確な皮膚の状態を検査できる。さらには、様々な皮膚の状態をより幅広く検査することができる。即ち、皮膚の状態に対して、第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14が、それぞれ異なった色を示すので、正確な皮膚の状態を検査できると共に、水分の多い皮膚も水分の少ない皮膚も幅広く検査することができる。さらには、第一吸収材料18、第二吸収材料19、および第三吸収材料20が、それぞれ異なった分泌物の吸収量を有することで、それぞれが対応する第一試薬保持部12、第二試薬保持部13、および第三試薬保持部14のそれぞれの色反応の開始タイミングを制御できる。   Since the first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14 are color-reacted at different reaction timings and color-reacted with secretions at the same speed, the reagent holding unit is For a single case, the skin condition can be accurately checked. Furthermore, various skin conditions can be examined more widely. That is, since the first reagent holding unit 12, the second reagent holding unit 13, and the third reagent holding unit 14 show different colors with respect to the skin state, the accurate skin state can be inspected, It is possible to examine a wide range of skin with high moisture and low moisture. Furthermore, the 1st absorption material 18, the 2nd absorption material 19, and the 3rd absorption material 20 have the absorption amount of a different secretion, respectively, The 1st reagent holding | maintenance part 12 and the 2nd reagent which each respond | correspond Each color reaction start timing of the holding unit 13 and the third reagent holding unit 14 can be controlled.

図8は、検査シート1の側方断面図の第三の実施形態を示す。検査シート1は、色見本5、表シート6、粘着層10、透明シート11、第一試薬保持部21、第二試薬保持部22、第三試薬保持部23、第一透過部27、第二透過部28、および第三透過部29を備える。   FIG. 8 shows a third embodiment of a side sectional view of the inspection sheet 1. The test sheet 1 includes a color sample 5, a front sheet 6, an adhesive layer 10, a transparent sheet 11, a first reagent holding unit 21, a second reagent holding unit 22, a third reagent holding unit 23, a first transmission unit 27, and a second. A transmission part 28 and a third transmission part 29 are provided.

なお、本実施形態に係る検査シート1は、第一試薬保持部21、第二試薬保持部22、および第三試薬保持部23が含む試薬の濃度がそれぞれ異なる点と、第一透過部27、第二透過部28、および第三透過部29が同一の浸透量を有する点を除き、図1から図4の上記説明における検査シート1と略同一の機能および構成を有する。また、第一透過部27、第二透過部28、および第三透過部29は、図5から図7における第一透過層15、第二透過層16、および第三透過層17と略同一の機能および構成を有する。従って、以下の説明においては、第一試薬保持部21、第二試薬保持部22、および第三試薬保持部23を除く他の構成要素についての詳細な説明は省略する。   Note that the test sheet 1 according to the present embodiment is different from the first reagent holding unit 21, the second reagent holding unit 22, and the third reagent holding unit 23 in that the concentrations of the reagents are different from each other, Except that the second transmission part 28 and the third transmission part 29 have the same penetration amount, the second transmission part 28 and the third transmission part 29 have substantially the same function and configuration as the inspection sheet 1 in the above description of FIGS. The first transmission part 27, the second transmission part 28, and the third transmission part 29 are substantially the same as the first transmission layer 15, the second transmission layer 16, and the third transmission layer 17 in FIGS. Has function and configuration. Therefore, in the following description, detailed description of the other components except the first reagent holding unit 21, the second reagent holding unit 22, and the third reagent holding unit 23 is omitted.

第一試薬保持部21は、第一透過部27の上面、即ち、皮膚と接触する面と反対の面に設けられる。第二試薬保持部22は、第二透過部28の上面、即ち、皮膚と接触する面と反対の面に設けられる。第三試薬保持部23は、第三透過部29の上面、即ち、皮膚と接触する面と反対の面に設けられる。   The first reagent holding unit 21 is provided on the upper surface of the first permeation unit 27, that is, the surface opposite to the surface in contact with the skin. The second reagent holding unit 22 is provided on the upper surface of the second permeation unit 28, that is, the surface opposite to the surface in contact with the skin. The third reagent holding unit 23 is provided on the upper surface of the third permeation unit 29, that is, the surface opposite to the surface in contact with the skin.

また、第一試薬保持部21、第二試薬保持部22、および第三試薬保持部23は、それぞれ異なった濃度の試薬を含む。なお、それぞれの試薬保持部が含む試薬の量は、単位面積当たりの試薬の量、または単位体積当たりの試薬の量を異ならせることで実現できる。本実施形態では、第一試薬保持部21、第二試薬保持部22、および第三試薬保持部23は、それぞれ薄い、中間、濃い濃度の試薬を含むものとする。   Moreover, the 1st reagent holding | maintenance part 21, the 2nd reagent holding | maintenance part 22, and the 3rd reagent holding | maintenance part 23 contain the reagent of a respectively different density | concentration. The amount of reagent contained in each reagent holding unit can be realized by varying the amount of reagent per unit area or the amount of reagent per unit volume. In the present embodiment, the first reagent holding unit 21, the second reagent holding unit 22, and the third reagent holding unit 23 include thin, intermediate, and high concentration reagents, respectively.

図9は、本発明の第三実施形態に係る試薬保持部の色の変化を示す。図9において、縦軸はそれぞれの試薬保持部の色の変化量を示し、横軸は皮膚から分泌した分泌物の蒸散量を示す。皮膚からの分泌物の蒸散量に対する、第一試薬保持部21の色の変化量をaに示す。皮膚からの分泌物の蒸散量に対する、第二試薬保持部22の色の変化量をbに示す。皮膚からの分泌物の蒸散量に対する、第三試薬保持部23の色の変化量をcに示す。なお、色の変化量とは、色相の変化量の他に、色が濃くなっていく量、および色が淡くなっていく量も含む。また、蒸散量に対するそれぞれの試薬保持部の色の変化する速さは、a、b、およびcの傾きで表される。   FIG. 9 shows the color change of the reagent holding part according to the third embodiment of the present invention. In FIG. 9, the vertical axis indicates the amount of change in the color of each reagent holding portion, and the horizontal axis indicates the transpiration amount of the secretion secreted from the skin. The amount of change in the color of the first reagent holding portion 21 with respect to the amount of transpiration of the secretion from the skin is shown in a. The amount of change in the color of the second reagent holding unit 22 with respect to the amount of transpiration of the secretion from the skin is shown in b. The amount of change in the color of the third reagent holding unit 23 relative to the amount of transpiration of the secretion from the skin is shown in c. The color change amount includes, in addition to the hue change amount, an amount that the color becomes darker and an amount that the color becomes lighter. Further, the speed at which the color of each reagent holder changes with respect to the amount of transpiration is represented by the slopes of a, b, and c.

検査開始から一定時間経過後における皮膚からの分泌物の蒸散量がkであった場合、第一試薬保持部21は、多くの試薬が反応して既に色が十分変化している状態を示す。第二試薬保持部22は、色変化が進行途上で、試薬の4/5が変化した状態を示す。第三試薬保持部23は、色変化が進行途上で、試薬の約半分が変化した状態を示す。このように、それぞれの試薬保持部が含む試薬は、異なった蒸散量で反応が完結する。   When the transpiration amount of the secretion from the skin after a lapse of a certain time from the start of the test is k, the first reagent holding unit 21 shows a state where the color has already sufficiently changed due to the reaction of many reagents. The second reagent holding unit 22 shows a state in which 4/5 of the reagent has changed while the color change is in progress. The third reagent holding unit 23 shows a state in which about half of the reagent has changed while the color change is in progress. As described above, the reagents contained in the respective reagent holding units complete the reaction with different transpiration amounts.

第一試薬保持部21、第二試薬保持部22、および第三試薬保持部23は、それぞれが異なった濃度の試薬を含むことで、試薬検査開始から一定時間経過後において、それぞれが異なった色を呈する。即ち、第一試薬保持部21、第二試薬保持部22、および第三試薬保持部23には色の差が生じる。この色の差により、第一試薬保持部21、第二試薬保持部22、および第三試薬保持部23の色反応の違いが見えやすくなるので、正確な皮膚の状態を検査できる。   The first reagent holding unit 21, the second reagent holding unit 22, and the third reagent holding unit 23 include different concentrations of reagents, so that different colors are obtained after a predetermined time has elapsed since the start of the reagent test. Presents. That is, color differences occur in the first reagent holding unit 21, the second reagent holding unit 22, and the third reagent holding unit 23. The difference in color makes it easy to see the difference in color reaction among the first reagent holding unit 21, the second reagent holding unit 22, and the third reagent holding unit 23, so that an accurate skin condition can be inspected.

検査シート1の正面図を示す。The front view of the test | inspection sheet 1 is shown. 色見本5の正面図を示す。The front view of the color sample 5 is shown. 検査シート1の側方断面図の第一の実施形態を示す。1st embodiment of the side sectional view of the test | inspection sheet 1 is shown. 本発明の第一実施形態に係る試薬保持部の色の変化を示す。The change of the color of the reagent holding part which concerns on 1st embodiment of this invention is shown. 検査シート1の側方断面図の第二の実施形態を示す。2nd embodiment of the side sectional view of the test | inspection sheet 1 is shown. 本発明の第二実施形態に係る試薬保持部の色の変化を示す。The change of the color of the reagent holding part which concerns on 2nd embodiment of this invention is shown. 本発明の第二実施形態に係る試薬保持部の色の変化における別の例を示す。The another example in the change of the color of the reagent holding part which concerns on 2nd embodiment of this invention is shown. 検査シート1の側方断面図の第三の実施形態を示す。3rd embodiment of the side sectional view of the test | inspection sheet 1 is shown. 本発明の第三実施形態に係る試薬保持部の色の変化を示す。The change of the color of the reagent holding part which concerns on 3rd embodiment of this invention is shown.

符号の説明Explanation of symbols

1 検査シート
5 色見本
6 表シート
7 第一透過部
8 第二透過部
9 第三透過部
10 粘着層
11 透明シート
12 第一試薬保持部
13 第二試薬保持部
14 第三試薬保持部
15 第一透過層
16 第二透過層
17 第三透過層
18 第一吸収材料
19 第二吸収材料
20 第三吸収材料
21 第一試薬保持部
22 第二試薬保持部
23 第三試薬保持部
24 第一透過部
25 第二透過部
26 第三透過部
27 第一透過部
28 第二透過部
29 第三透過部
DESCRIPTION OF SYMBOLS 1 Test sheet 5 Color sample 6 Table sheet 7 1st permeation | transmission part 8 2nd permeation | transmission part 9 3rd permeation | transmission part 10 Adhesive layer 11 Transparent sheet 12 1st reagent holding | maintenance part 13 2nd reagent holding | maintenance part 14 3rd reagent holding | maintenance part 15 1st One permeable layer 16 Second permeable layer 17 Third permeable layer 18 First absorbent material 19 Second absorbent material 20 Third absorbent material 21 First reagent holding part 22 Second reagent holding part 23 Third reagent holding part 24 First permeation Part 25 Second transmission part 26 Third transmission part 27 First transmission part 28 Second transmission part 29 Third transmission part

Claims (9)

皮膚から発生する分泌物と接触することによって色が変化する同一の試薬それぞれを含み、同一量の前記分泌物に対して、色の変化の状態がそれぞれ異なる複数の試薬保持部
を備える検査シート。
A test sheet comprising a plurality of reagent holders each containing the same reagent that changes color by contact with secretions generated from the skin and having different color change states for the same amount of the secretions.
前記複数の試薬保持部は、同一量の前記分泌物に対して、単位時間当たりの色の変化量がそれぞれ異なる請求項1に記載の検査シート。   2. The test sheet according to claim 1, wherein the plurality of reagent holding units have different amounts of color change per unit time with respect to the same amount of the secretion. 前記複数の試薬保持部の前記皮膚に対向する面に隣接してそれぞれ設けられ、前記分泌物をそれぞれ透過する複数の透過部
をさらに備え、
前記複数の透過部は、単位時間当たりに前記皮膚から前記複数の試薬保持部のそれぞれに到達させる前記分泌物の量がそれぞれ異なる請求項2に記載の検査シート。
Each of the plurality of reagent holding portions is provided adjacent to a surface facing the skin, and further includes a plurality of permeation portions that respectively permeate the secretions.
The test sheet according to claim 2, wherein the plurality of permeation units have different amounts of the secretions that reach each of the plurality of reagent holding units from the skin per unit time.
前記複数の透過部は、前記皮膚から前記複数の試薬保持部のそれぞれへ貫通する貫通孔を有し、
前記複数の透過部がそれぞれ有する前記貫通孔の大きさがそれぞれ異なる請求項3に記載の検査シート。
The plurality of permeation portions have through holes penetrating from the skin to each of the plurality of reagent holding portions,
The inspection sheet according to claim 3, wherein each of the plurality of transmission parts has different sizes of the through holes.
前記複数の透過部は、前記皮膚から前記複数の試薬保持部のそれぞれへ貫通する貫通孔を有し、
前記複数の透過部がそれぞれ有する前記貫通孔の単位面積当たりの数がそれぞれ異なる請求項3に記載の検査シート。
The plurality of permeation portions have through holes penetrating from the skin to each of the plurality of reagent holding portions,
The inspection sheet according to claim 3, wherein the number of the through holes that each of the plurality of transmission portions has per unit area is different.
前記複数の試薬保持部は、同一量の前記分泌物に対して、色の変化が開始するタイミングがそれぞれ異なる請求項1に記載の検査シート。   The test sheet according to claim 1, wherein the plurality of reagent holding units have different timings at which a color change starts for the same amount of the secretion. 前記複数の試薬保持部の前記皮膚に対向する面に隣接してそれぞれ設けられ、前記分泌物をそれぞれ透過する複数の透過部
をさらに備え、
前記複数の透過部は、前記分泌物を前記複数の試薬保持部のそれぞれに到達させるまでの時間がそれぞれ異なる請求項6に記載の検査シート。
Each of the plurality of reagent holding portions is provided adjacent to a surface facing the skin, and further includes a plurality of permeation portions that respectively permeate the secretions.
The test sheet according to claim 6, wherein the plurality of permeation units have different times until the secretions reach each of the plurality of reagent holding units.
前記複数の透過部は、前記分泌物を吸収する材料を有し、前記分泌物の吸収量がそれぞれ異なる請求項7に記載の検査シート。   The test sheet according to claim 7, wherein the plurality of transmission parts include a material that absorbs the secretion, and the amount of absorption of the secretion is different. 前記複数の試薬保持部がそれぞれ含む前記試薬の濃度がそれぞれ異なる請求項1に記載の検査シート。   The test sheet according to claim 1, wherein the concentrations of the reagents included in the plurality of reagent holding units are different from each other.
JP2007142489A 2007-05-29 2007-05-29 Inspection sheet Active JP4868409B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007142489A JP4868409B2 (en) 2007-05-29 2007-05-29 Inspection sheet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007142489A JP4868409B2 (en) 2007-05-29 2007-05-29 Inspection sheet

Publications (2)

Publication Number Publication Date
JP2008298481A true JP2008298481A (en) 2008-12-11
JP4868409B2 JP4868409B2 (en) 2012-02-01

Family

ID=40172145

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007142489A Active JP4868409B2 (en) 2007-05-29 2007-05-29 Inspection sheet

Country Status (1)

Country Link
JP (1) JP4868409B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016003960A (en) * 2014-06-17 2016-01-12 地方独立行政法人東京都立産業技術研究センター Material for pressure measurement and manufacturing method of the same, and pressure measurement method
KR20160024780A (en) * 2014-08-25 2016-03-07 제록스 코포레이션 Design of paper sensor

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59158046A (en) * 1983-02-28 1984-09-07 松下電工株式会社 Electromagnetically repulsion contactor unit
JPS61178663A (en) * 1985-02-01 1986-08-11 マイルス・ラボラトリーズ・インコーポレーテツド Stable chloride test tool, manufacture thereof and measurement method using said tool
JPH0777525A (en) * 1993-07-15 1995-03-20 Boehringer Mannheim Gmbh Method and device for simultaneous measurement of plurality of materials to be analyzed
JPH09238907A (en) * 1996-03-06 1997-09-16 Kose Corp Sebum quantity measuring apparatus
JPH1147097A (en) * 1997-08-01 1999-02-23 Moritex Corp Fat and oil measuring instrument
JP2004236794A (en) * 2003-02-05 2004-08-26 Life Kea Giken Kk Test sheet for skin moisture retention function

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59158046A (en) * 1983-02-28 1984-09-07 松下電工株式会社 Electromagnetically repulsion contactor unit
JPS61178663A (en) * 1985-02-01 1986-08-11 マイルス・ラボラトリーズ・インコーポレーテツド Stable chloride test tool, manufacture thereof and measurement method using said tool
JPH0777525A (en) * 1993-07-15 1995-03-20 Boehringer Mannheim Gmbh Method and device for simultaneous measurement of plurality of materials to be analyzed
JPH09238907A (en) * 1996-03-06 1997-09-16 Kose Corp Sebum quantity measuring apparatus
JPH1147097A (en) * 1997-08-01 1999-02-23 Moritex Corp Fat and oil measuring instrument
JP2004236794A (en) * 2003-02-05 2004-08-26 Life Kea Giken Kk Test sheet for skin moisture retention function

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016003960A (en) * 2014-06-17 2016-01-12 地方独立行政法人東京都立産業技術研究センター Material for pressure measurement and manufacturing method of the same, and pressure measurement method
KR20160024780A (en) * 2014-08-25 2016-03-07 제록스 코포레이션 Design of paper sensor
JP2016045199A (en) * 2014-08-25 2016-04-04 ゼロックス コーポレイションXerox Corporation Design of paper sensor
KR102266347B1 (en) 2014-08-25 2021-06-18 제록스 코포레이션 Design of paper sensor

Also Published As

Publication number Publication date
JP4868409B2 (en) 2012-02-01

Similar Documents

Publication Publication Date Title
EP0475692B1 (en) Visual blood glucose concentration test strip
JP3173798B2 (en) Method and apparatus for determining an analyte of a body fluid
CA3055783C (en) Colorometric sensor for the non-invasive screening of glucose in sweat in pre and type 2 diabetes
JPH0674953A (en) Test strip, which has moving medium and guides fluid
US20030186457A1 (en) Blood testing unit and blood testing method and apparatus
CA2471216A1 (en) Liquid sample assay device
TW200307133A (en) Blood tester
CN105021596A (en) Concentration gradient based dry chemical test strip with multiple layers of films
KR20180085577A (en) Attaching type chemical snesor comprising hydrogel and method for preparing the same
CN113574385A (en) Lateral flow device
CN201540288U (en) Dry chemical test paper for quantitatively measuring content of urea of body blood
US20090155924A1 (en) System, method and device for detection of substances on surfaces
JP4868409B2 (en) Inspection sheet
CN104937106A (en) Systems and methods for monitoring biological fluids
US20150198581A1 (en) Method, mobile application, and system for providing food safety map
WO2018165180A1 (en) Colorometric sensor for the non-invasive screening of glucose in sweat in pre and type 2 diabetes
JP2008164520A (en) Detection device utilizing antigen-antibody reaction
JP2000503776A (en) Method and apparatus for colorimetric determination of an analyte in the presence of particulate interfering substances
CN1918472B (en) Multilayer analysis element (intensity of porous film)
Donato et al. Ink-jet printed colorimetric sensor for the determination of Fe (II)
CN203758917U (en) Dry chemistry test paper for quantitatively measuring content of albumins in human body blood
ES2879813T3 (en) Systems and procedures for sample verification
KR102009116B1 (en) Test strip
JP4493535B2 (en) Test paper
JP2004333212A (en) Liquid physical property measuring apparatus

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100210

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20110706

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110726

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110922

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20111018

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20111109

R150 Certificate of patent or registration of utility model

Ref document number: 4868409

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141125

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250